Status:
COMPLETED
Reliability and Equivalence of Alternate Forms of the Digital Clock Drawing Test
Lead Sponsor:
Linus Health, Inc.
Conditions:
Cognitive Function
Eligibility:
All Genders
55-95 years
Phase:
NA
Brief Summary
Equivalence of DCTclock-pen and DCTclock-tablet will be tested in a randomized crossover trial.
Detailed Description
Randomized crossover trial consisting of two test visits separated by a washout period of 3 to 5 weeks. Subjects are randomized into two equal groups. Group 1 receives the digital pen (DCTclock-pen) v...
Eligibility Criteria
Inclusion
- 55-95 years old
Exclusion
- Ineligible for written informed consent
- Impairment of the writing hand that precludes ability to perform the study tasks
- Impaired manual dexterity in the writing hand
- Impaired vision in both eyes
- Under the influence of recreational drugs or alcohol at the time of the visit.
- Current or recent participation in a clinical trial that includes the use of a drug or intervention to alter cognitive function.
- Recent (within the last 6 months) cognitive testing with a Clock Drawing Test.
- Visit 2 Only- Self-reported change (addition or discontinuation) of the following medications between visit 1 and visit 2; Timolol (eye drop), Benadryl, beta blockers, steroids or over the counter medications for sleep (PM varieties).
Key Trial Info
Start Date :
December 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 16 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04496752
Start Date
December 18 2020
End Date
November 16 2021
Last Update
March 7 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Clincloud Research
Maitland, Florida, United States, 32751
2
Clinilabs
Eatontown, New Jersey, United States, 07724